0001209191-23-031485.txt : 20230522
0001209191-23-031485.hdr.sgml : 20230522
20230522164525
ACCESSION NUMBER: 0001209191-23-031485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230522
DATE AS OF CHANGE: 20230522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nohaile Michael
CENTRAL INDEX KEY: 0001890563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 23945189
MAIL ADDRESS:
STREET 1: C/O BIO AI ACCELERATION COMPANY
STREET 2: 20 UNIVERSITY AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-18
0
0001674930
Fulgent Genetics, Inc.
FLGT
0001890563
Nohaile Michael
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE
EL MONTE
CA
91731
1
0
0
0
0
Common Stock
2023-05-18
4
A
0
2529
0.00
A
6529
D
Stock Option (Right to Buy)
35.58
2023-05-18
4
A
0
3380
0.00
A
2033-05-17
Common Stock
3380
3380
D
Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
/s/ Paul Kim as Attorney-in-fact
2023-05-22